Covered recipient · General Payments record
DARRICK J ALAIMO
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$91,119.61
- Reported across 853 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $7,625.00 | 2 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,714.00 | 1 |
| Food and Beverage | $3,271.81 | 127 |
| Travel and Lodging | $631.50 | 4 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $8,843.50 | 22 |
| GENZYME CORPORATION | $4,174.62 | 9 |
| ABBVIE INC. | $634.66 | 40 |
| PFIZER INC. | $356.33 | 21 |
| EISAI INC. | $204.43 | 4 |
| JAZZ PHARMACEUTICALS INC. | $179.34 | 4 |
| Neurocrine BioSciences, Inc. | $110.04 | 4 |
| Amneal Pharmaceuticals LLC | $106.36 | 3 |
| Kyowa Kirin, Inc. | $99.34 | 4 |
| ARGENX US, INC. | $86.33 | 3 |
| EMD Serono, Inc. | $61.01 | 2 |
| Lundbeck LLC | $57.77 | 3 |
| Genentech USA, Inc. | $46.31 | 2 |
| CSL Behring | $35.80 | 2 |
| SK Life Science, Inc. | $27.59 | 1 |
| Biogen, Inc. | $25.87 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $25.05 | 1 |
| TG THERAPEUTICS, INC. | $23.25 | 1 |
| Teva Pharmaceuticals USA, Inc. | $23.06 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $22.04 | 1 |
| MDD US Operations, LLC | $21.80 | 1 |
| Alnylam Pharmaceuticals Inc. | $20.79 | 1 |
| Alexion Pharmaceuticals, Inc. | $20.38 | 1 |
| Inspire Medical Systems, Inc. | $19.50 | 1 |
| MITSUBISHI TANABE PHARMA AMERICA, INC. | $17.14 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (134)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.